Correction: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

2015 ◽  
Vol 21 (9) ◽  
pp. 2192-2192 ◽  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Advanced Solid Tumors ◽  
Pharmacodynamic Study ◽  
Correction Phase

scholarly journals Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

2013 ◽  
Vol 20 (1) ◽  
pp. 233-245 ◽  
Author(s):  
Geoffrey I. Shapiro ◽  
Jordi Rodon ◽  
Cynthia Bedell ◽  
Eunice L. Kwak ◽  
Jose Baselga ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Advanced Solid Tumors ◽  
Pharmacodynamic Study

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

2014 ◽  
Vol 32 (4) ◽  
pp. 670-681 ◽  
Author(s):  
Jordi Rodon ◽  
Irene Braña ◽  
Lillian L Siu ◽  
Maja J De Jonge ◽  
Natasha Homji ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Advanced Solid Tumors

scholarly journals Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

2018 ◽  
Vol 23 (4) ◽  
pp. 401 ◽  
Author(s):  
Gerald Edelman ◽  
Jordi Rodon ◽  
Joanne Lager ◽  
Christelle Castell ◽  
Jason Jiang ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Trial ◽  
Tablet Formulation ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Advanced Solid Tumors

A first-in-human phase I study of BKM120, an oral pan-class I PI3K inhibitor, in patients (pts) with advanced solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 3003-3003 ◽  
Author(s):  
J. Baselga ◽  
M. J. De Jonge ◽  
J. Rodon ◽  
H. A. Burris ◽  
D. C. Birle ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Pi3k Inhibitor ◽  
Class I ◽  
Advanced Solid Tumors

scholarly journals Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma

2011 ◽  
Vol 30 (6) ◽  
pp. 2294-2302 ◽  
Author(s):  
Jason Konner ◽  
Rachel N. Grisham ◽  
Jae Park ◽  
Owen A. O’Connor ◽  
Gillian Cropp ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Clinical Pharmacokinetic ◽  
Advanced Solid Tumors ◽  
Epothilone D ◽  
Pharmacodynamic Study

scholarly journals A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients with Advanced Solid Tumors

2007 ◽  
Vol 13 (7) ◽  
pp. 2109-2114 ◽  
Author(s):  
Ramesh K. Ramanathan ◽  
D. Lynn Kirkpatrick ◽  
Chandra P. Belani ◽  
David Friedland ◽  
Sylvan B. Green ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Advanced Solid Tumors ◽  
Thioredoxin 1 ◽  
Pharmacodynamic Study
Sign in / Sign up

Export Citation Format

Share Document